Finance Watch: Lilly Toes The $1 Trillion Valuation Line

Nuvalent’s Post-Data Offering Brings In $500m

Finance Watch Public Company
• Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Scrip

More from Finance Watch